BESTSELLER

Electronic Clinical Outcome Assessment Solutions (eCOA) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Electronic Clinical Outcome Assessment Solutions (eCOA)Market is segmented by Delivery Mode, Approach, End User(Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Others), and Geography.

Market Snapshot

eCOA
Study Period:

2018 - 2026

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

16.18 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors found propelling the growth of the market include the high demand for clinical trials in emerging markets, high R&D spending of the pharmaceutical industry, increasing prevalence of diseases, and inclination from manual data interpretation to real-time data analysis are expected to offer significant growth opportunities for global players during the study period.

Moreover, regulatory agencies have increasingly highlighted the significance of evaluating broader characteristics of patient well-being to define therapeutic gain in an enhanced manner. As a result, clinical outcome assessments (COAs) are increasingly used to estimate the impact of treatments for various chronic disorders, and in some instances, these have played a major role in the regulatory approval of drugs.

However, data privacy concerns and high implementation costs are acting as major restraints for the growth of the market.

Scope of the report

As per the scope of this report, electronic clinical outcome assessment (eCOA) uses the technology, such as smartphones, tablets, and computers, to allow the patients, caregivers, and doctors to directly report the outcomes of clinical trials. eCOA produces highly accurate data that allows for a better understanding of the patient experience in clinical trials, and ultimately helps simplify the path to approval.

By Delivery Mode
Web Hosted
Cloud Based
By Approach
Patient-reported outcome (PRO)
Clinician-reported outcome (ClinRO)
Observer-reported outcome (ObsRO)
Performance outcome (PerfO)
End-User
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-Eastst and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

web-hosted eCOA Segment expected to Grow at Significant Rate

With the increasing use of eCOA, additional modifications have provided a detailed understanding of the proper use of eCOA, for more benefits and improvisation of the data quality.

The web-hosted eCOA gives more compatibility to clinicians, as it is easy to operate and can keep the whole record throughout the clinical trials, from Phase I to IV.

Web-hosted eCOA solutions help reduce the development timeline and provide faster results. These solutions are helpful in the administration of clinical trials. For instance, the web-hosted eCOA helps in real-time management, instant alerts, and consistency check during clinical trials.nWith increasing use of tablets and smartphones, web-hosted eCOA has become easily accessible. The ease of access is one of the prime factors responsible for the increasing use of web-hosted eCOA, among clinicians and patients.

clinical-trials-market_CTmarket-2020-1.webp

To understand key trends, Download Sample Report

North America Expected to have Significant Market Share

Electronic Clinical Outcome Assessment Solutions (eCOA) Market in North America is anticipated to grow significantly, due to rising clinical trials across the country. With the rising demand for drug development, the clinical trials are rapidly increasing in the United States and Canada. 

In addition, constant advancements in eCOA modalities and strategic collaborations between major market players are contributing to the rising demand for these solutions in the country. For instance, In June 2018, OmniComm Systems Inc. and Kayentis entered a partnership, under the terms of the partnership, the two companies are expected to work together to provide life science clients with OmniComm’s TrialMaster electronic data capture (EDC) suite integrated with Clin’form, eCOA solution Suite from Kayentis, thereby, offering enhanced integration of the two platforms.

The clinicians across the region rely on novel technologies for data management. Owing to the significance of eCOA solutions in providing ease of access, clinicians are proffering these platforms for clinical trial management.

Electronic Clinical Outcome Assessment Solutions (eCOA)

To understand geography trends, Download Sample Report

Competitive Landscape

Electronic Clinical Outcome Assessment Solutions (eCOA) market is moderately fragmented and competitive. Market players are focusing on new product launches and regional expansions to increase their market share. The key market players operating in the market include IQVIA Inc., Veeva Systems, Parexel International Corporation, Signant Health, WIRB-Copernicus Group amongst others.

Recent Developments

 

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Externalization of Clinical Trial Studies by Large Pharmaceutical and Biopharmaceutical Companies

      2. 4.2.2 Growing Demand for Cloud Based Services

      3. 4.2.3 Constant Advancements in eCOA Modalities

    3. 4.3 Market Restraints

      1. 4.3.1 Data Security and Privacy Concerns

      2. 4.3.2 High Cost of Implementation

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Delivery Mode

      1. 5.1.1 Web Hosted

      2. 5.1.2 Cloud Based

    2. 5.2 By Approach

      1. 5.2.1 Patient-reported outcome (PRO)

      2. 5.2.2 Clinician-reported outcome (ClinRO)

      3. 5.2.3 Observer-reported outcome (ObsRO)

      4. 5.2.4 Performance outcome (PerfO)

    3. 5.3 End-User

      1. 5.3.1 Pharmaceutical and Biopharmaceutical Companies

      2. 5.3.2 Contract Research Organizations

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-Eastst and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Oracle Corporation

      2. 6.1.2 Castor EDC

      3. 6.1.3 Dassault Systmes (medidata)

      4. 6.1.4 ERT Clinical

      5. 6.1.5 IQVIA Inc.

      6. 6.1.6 Kayentis

      7. 6.1.7 Veeva Systems

      8. 6.1.8 Parexel International Corporation

      9. 6.1.9 Signant Health.

      10. 6.1.10 WIRB-Copernicus Group

      11. 6.1.11 Mednet Solutions

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Electronic Clinical Outcome Assessment Solutions Market market is studied from 2018 - 2026.

The Electronic Clinical Outcome Assessment Solutions Market is growing at a CAGR of 16.18% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2019.

  • Kayentis
  • IQVIA Inc.
  • Parexel International Corporation
  • Signant Health
  • WIRB-Copernicus Group

Are the major companies operating in Electronic Clinical Outcome Assessment Solutions Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!